XML 28 R14.htm IDEA: XBRL DOCUMENT
v3.22.4

Note 7 - Identified Intangible Assets | 12 Months Ended
--- | ---
Dec. 31, 2022
Notes to Financial Statements |
Intangible Assets Disclosure [Text Block] | 7. IDENTIFIED INTANGIBLE ASSETS A schedule of identified intangible assets is as follows:
|  | Gross |  |  | Accumulated |  |  | Carrying |
($ in thousands) |  | Amount |  |  | Amortization |  |  | Amount |
December 31, 2022 |  |  |  |  |  |  |  |  |  |  |  |
Trademarks |  |  |  |  |  |  |  |  |  |  |  |
Wholesale (1) |  | $ | 71,979 |  |  |  | - |  |  | $ | 71,979 |
Retail (2) |  |  | 9,220 |  |  |  | - |  |  |  | 9,220 |
Patents |  |  | 895 |  |  | $ | 826 |  |  |  | 69 |
Customer relationships (3) |  |  | 46,006 |  |  |  | 5,492 |  |  |  | 40,514 |
Total Intangibles |  | $ | 128,100 |  |  | $ | 6,318 |  |  | $ | 121,782 |
(1) $45.4 million of the total resulted from our Acquisition that occurred on March 15, 2021. NEOS trademarks were reduced from approximately $0.6 million to zero at December 31, 2022 as a result of the sale of the NEOS bran d (see Note 4 ). (2) $6.3 million of the total resulted from our Acquisition that occurred on March 15, 2021. (3) Resulted from our Acquisition that occurred on March 15, 2021. Customer relationships relating to the NEOS brand of approximately $0.9 million and related amortization of approximately $0.1 million was reduced to zero at December 31, 2022 as a result of the sale of the NEOS br and (see Note 4 ).
|  | Gross |  |  | Accumulated |  |  | Carrying |
($ in thousands) |  | Amount |  |  | Amortization |  |  | Amount |
December 31, 2021 |  |  |  |  |  |  |  |  |  |  |  |
Trademarks |  |  |  |  |  |  |  |  |  |  |  |
Wholesale (1) |  | $ | 72,579 |  |  |  | - |  |  | $ | 72,579 |
Retail (2) |  |  | 9,220 |  |  |  | - |  |  |  | 9,220 |
Patents |  |  | 895 |  |  | $ | 804 |  |  |  | 91 |
Customer relationships (3) |  |  | 46,900 |  |  |  | 2,475 |  |  |  | 44,425 |
Total Intangibles |  | $ | 129,594 |  |  | $ | 3,279 |  |  | $ | 126,315 |
(1) $45.4 million of the total resulted from our Acquisition that occurred on March 15, 2021. (2) $6.3 million of the total resulted from our Acquisition that occurred on March 15, 2021. (3) Resulted from our Acquisition that occurred on March 15, 2021. The weighted average remaining life for our patents is 7.1 years. A schedule of approximate actual and expected amortization expense related to finite-lived intangible assets is as follows:
|  | Amortization |
($ in thousands) |  | Expense |
2023 |  |  | 3,011 |
2024 |  |  | 3,074 |
2025 |  |  | 3,070 |
2026 |  |  | 3,067 |
2027 |  |  | 3,064 |
2028+ |  |  | 25,297 |
Indefinite lived intangible assets, such as trademarks are reviewed for impairment testing annually, more frequently if necessary. We perform such testing of indefinite-lived intangible assets in the fourth quarter of each year or as events occur or circumstances change that would more likely than not reduce the fair value of the asset below its carrying amount. Fair value of other indefinite-lived intangible assets is determined using the relief from royalty method. Definite lived intangible assets, such as patents and customer relationships are only reviewed for impairment if a triggering event has occurred to indicate that its fair value of the asset is below its carrying value. In assessing whether indefinite-lived intangible assets are impaired, we must make certain estimates and assumptions regarding future cash flows, long-term growth rates of our business, operating margins, weighted average cost of capital and other factors such as: discount rates, royalty rates, cost of capital, and market multiples to determine the fair value of our assets. These estimates and assumptions require management’s judgment, and changes to these estimates and assumptions could materially affect the determination of fair value and/or impairment for each of our indefinite-lived intangible assets. Future events could cause us to conclude that indications of intangible asset impairment exist. Impairment may result from, among other things, deterioration in the performance of our business, adverse market conditions, adverse changes in applicable laws and regulations, competition, or the sale or disposition of a reporting segment. Any resulting impairment loss could have a material adverse impact on our financial condition and results of operations. 2022 and 2021 Impairment Testing We evaluate our finite and indefinite lived intangible assets under the terms and provisions of the accounting standards for "Intangibles - Goodwill and Other" and "Property, Plant and Equipment." These pronouncements require that we compare the fair value of an intangible asset with its carrying amount. The results of our 2022 and 2021 finite and indefinite-lived intangible impairment testing indicated that all reporting unit intangible asset fair values exceed their respective carrying values.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -URI https://asc.fasb.org/subtopic&trid=2144471 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration